I'm not going to attack anyone on my block. Unless they ask for it. Below I've asked Claude to dive into this. My take: The EU economy has been devestated by the loss of cheap Russian energy which is making manufacturing uneconomic. Germany is the shining example of this. The war will end, when Russia gets the Donbas and it's energy/mineral assets. In return the EU will resume business as usual and starting buying Russian oil. Putin isn't going to stop till he gets the Do

Thomas Snitzer has endorsed a six panel door as a write in candidate for Maine's US Senate race. Bill Maher makes shocking recommendation in Maine Senate race after Graham Platner’s ‘scary behavior’ By Ryan King, NY Post Published June 14, 2026 Comedian Bill Maher threw his weight behind Maine Democratic Senate hopeful Graham Platner, despite his “scary behavior,” arguing that flipping the Senate for Dems is more important than his Nazi tattoo or cheating scandal. HBO’s “Rea

British PM Starmer yesterday singled out the Spritzler Report saying "It's time for our youngsters to stop drinking from the depraved firehose of smut. Mr. Snitzer passes himself off as a journalist but desperately needs psychiatric attention". The Report's CEO responded with a $56 million dollar libel suit filed in a Delaware Federal Court. U.K. to Ban Under-16s From Major Social-Media Platforms Britain says its ban, set to come into force next year, will go further than re

Commuting in from the suburbs 2-3 days a week is a game changer. Oh sorry, forgot...I never leave my home base in Arlington F-cking Heights. Work From Home Is Here to Stay—Even if Some CEOs Don’t Love It Big companies keep trumpeting return-to-office mandates, but the amount of time Americans work remotely is barely budging By Justin Lahart, WSJ June 15, 2026 Data indicate remote work has reached an equilibrium, with 26% of paid, full days worked from home in May, similar to

Medicare GLP-1 coverage may swamp docs By Tina Reed, Axios Nes June 15, 2026 Next month's launch of a Medicare program providing weight-loss drugs for $50 a month is expected to unleash pent-up demand for Wegovy, Zepbound and other blockbuster treatments — and create new bottlenecks at doctors' offices. The big picture: It could become one of the biggest drug rollouts ever — and it could test an already burdened system as seniors seek new GLP-1 prescriptions. Clinicians worr